{{Rsnum
|rsid=12691
|Gene=CEBPA
|Chromosome=19
|position=33300221
|Orientation=plus
|GMAF=0.1442
|Gene_s=CEBPA
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 65.2 | 32.1 | 2.7
| HCB | 96.9 | 3.1 | 0.0
| JPT | 90.2 | 9.8 | 0.0
| YRI | 48.3 | 41.3 | 10.5
| ASW | 59.6 | 35.1 | 5.3
| CHB | 96.9 | 3.1 | 0.0
| CHD | 97.2 | 2.8 | 0.0
| GIH | 90.0 | 9.0 | 1.0
| LWK | 46.3 | 44.4 | 9.3
| MEX | 64.9 | 33.3 | 1.8
| MKK | 65.4 | 32.0 | 2.6
| TSI | 62.0 | 38.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22269963
|Title=A gene variation (rs12691) in the CCAT/enhancer binding protein α modulates glucose metabolism in metabolic syndrome
}}

{{PMID Auto
|PMID=18765514
|Title=CCAAT/enhancer binding protein alpha (C/EBPalpha) in adipose tissue regulates genes in lipid and glucose metabolism and a genetic variation in C/EBPalpha is associated with serum levels of triglycerides.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}